Several pieces of evidence show that microglial activation of NOX2 is implicated in the pathogenesis of NDs including Alzheimer’s disease (AD), Parkinson’s disease (PD), and Amyotrophic Lateral Sclerosis (ALS) [8]. The gene discussed is CYBB; the disease is early-onset autosomal dominant Alzheimer disease.